John Ternus Signals Apple’s Future with Product-First AI Strategy 
Amazon Stock Rises as Meta Expands AWS Partnership for AI Infrastructure 
Florida Launches Criminal Probe Into OpenAI Over FSU Shooting Incident 
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges 
Apple Stock Dips as Tim Cook Steps Down, John Ternus Named Next CEO 
SK Hynix Reports Record Q1 Profit Surge Driven by AI Memory Chip Demand 
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal 
Mercedes-Benz Faces Rising Competition in China but Rejects Price War Strategy 
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting 
European Car Sales Surge in March as EV and Hybrid Demand Accelerates 
Intel Stock Surges as AI Chip Demand Drives Strong Q2 Forecast 
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO 
Hyundai Plans 20 New Models in China to Boost EV Strategy and Market Share 
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows 
Meta Expands AI Training With Employee Activity Tracking Tools 
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus 
Tesla Earnings Beat Expectations as EV Growth Holds Amid Robotics and AI Shift 
LOS ANGELES, March 18, 2017 -- Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Natus Medical Incorporated (“Natus” or the “Company”) (Nasdaq:BABY). Investors who purchased or otherwise acquired Natus shares between October 16, 2015 and April 3, 2016 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the March 31, 2016 lead plaintiff motion deadline.
To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at [email protected].
No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.
According to the Complaint, during the Class Period, Natus released materially false and/or misleading statements, as well as failed to disclose material adverse facts about its business, operations, and prospects, including that: the government of Venezuela was unable to spend tens of millions of dollars in prepayments to Natus, needed in October 2015; that Natus did not have the capacity to effectively enforce its rights under its supply contract; Natus’ revenues related to the supply contract were dependent on the results of Venezuelan elections; and as therefore, Natus could not actually achieve the increased guidance offered by Defendants, which lacked a reasonable basis.
When this information was revealed to the public, the value of Natus Medical Incorporated stock declined, causing investors harm.
Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact: Lundin Law PC Brian Lundin, Esq. Telephone: 888-713-1033 Facsimile: 888-713-1125 [email protected] http://lundinlawpc.com/
